Trial · NCT02929329
Adverse events2,392
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 2,392
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Cardiac failure | Cardiac disorders | Placebo | 291 | 4,101 | |
| other | Cardiac failure | Cardiac disorders | Omecamtiv Mecarbil | 268 | 4,110 | |
| other | Hyperkalaemia | Metabolism and nutrition disorders | Placebo | 213 | 4,101 | |
| other | Hyperkalaemia | Metabolism and nutrition disorders | Omecamtiv Mecarbil | 202 | 4,110 | |
| other | Dizziness | Nervous system disorders | Placebo | 183 | 4,101 | |
| other | Dizziness | Nervous system disorders | Omecamtiv Mecarbil | 232 | 4,110 | |
| other | Dyspnoea | Respiratory, thoracic and mediastinal disorders | Placebo | 258 | 4,101 | |
| other | Dyspnoea | Respiratory, thoracic and mediastinal disorders | Omecamtiv Mecarbil | 249 | 4,110 | |
| other | Hypertension | Vascular disorders | Placebo | 222 | 4,101 | |
| other | Hypertension | Vascular disorders | Omecamtiv Mecarbil | 190 | 4,110 | |
| other | Hypotension | Vascular disorders | Placebo | 242 | 4,101 | |
| other | Hypotension | Vascular disorders | Omecamtiv Mecarbil | 276 | 4,110 | |
| serious | Anaemia | Blood and lymphatic system disorders | Placebo | 28 | 4,101 | |
| serious | Anaemia | Blood and lymphatic system disorders | Omecamtiv Mecarbil | 34 | 4,110 | |
| serious | Anaemia of chronic disease | Blood and lymphatic system disorders | Placebo | 2 | 4,101 | |
| serious | Anaemia of chronic disease | Blood and lymphatic system disorders | Omecamtiv Mecarbil | 0 | 4,110 | |
| serious | Anaemia vitamin B12 deficiency | Blood and lymphatic system disorders | Placebo | 1 | 4,101 | |
| serious | Anaemia vitamin B12 deficiency | Blood and lymphatic system disorders | Omecamtiv Mecarbil | 1 | 4,110 | |
| serious | Blood loss anaemia | Blood and lymphatic system disorders | Placebo | 2 | 4,101 | |
| serious | Blood loss anaemia | Blood and lymphatic system disorders | Omecamtiv Mecarbil | 2 | 4,110 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02929329/events